 LAVAL, Québec, Jan. 03, 2022 GLOBE NEWSWIRE -- Acasti Pharma Inc. Acasti or the Company Nasdaq: ACST and TSX-V: ACST, today announced that Jan DAlvise, President and CEO of Acasti, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. 